The acquisition would mark General Atlantic’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences.

The $33 million investment, which has both, primary and secondary components, will also provide Kotak Private Equity, an early investor in ...

Evertsone Capital, a mid-market equity firm, is stepping up its deal-making pace and with this investment in Rubicon, a contract research a...

The India and Southeast Asia-focused Everstone has assets under management of USD3.3 billion and is headquartered in Singapore.

Rubicon Research will also raise primary capital by selling another 20-25% through this round of fundraising that values the company at $20...

The government has begun speeding up approvals in the area of clinical research which is set to boom in India.

Kotak Private Equity said on Tuesday that it has invested in Rubicon Research, a product development company.

Innovation, international partnerships, collaborations, inflow of funds, clinical trials partnerships and co-development deals are changing...